Table of Contents
-
Treatment of hepatitis CImpact on the virus, the quality of life and the natural history
-
Minimal criteria for treatment chronic hepatitis C
(NIH 1997, EASL, 1999)
-
Definitions of response
-
Definitions of response
-
Treatment of chronic hepatitis CThe past
-
Treatment of chronic hepatitis CThe present
-
ET and Sustained Virological Response
-
PPT Slide
-
PPT Slide
-
EASL Consensus Conference, Feb 1999
-
Treatment of chronic hepatitis CThe near future
-
PEGINTRON + RIBAVIRINSustained Virological Response
Manns et al., Lancet 358, 958, 2001
-
PEGASYS + RIBAVIRINFried et al., DDW, May 2001
-
PEGASYS + RIBAVIRINSVR by genotype Fried et al., DDW, May 2001
-
Treatment of chronic hepatitis CThe (far) future
-
Health-related quality of life (HRQL)
-
Effect chronic hepatitis C on HRQLBonkovsky et al., Hepatology 29, 267, 1999
-
Effect treatment chronic hepatitis C on HRQLBonkovsky et al., Hepatology 29, 267, 1999
-
Effect of treatment on the natural history of chronic hepatitis C
-
Therapy of chronic hepatitis C Cost-effectiveness analyses
-
Guidelines acceptability cost-effectiveness ratio ($/QALY)
-
Therapy of chronic hepatitis CMarginal cost-effectiveness ratio ($,€/QALY saved)
-
Treatment of acute hepatitis C
-
Conclusions (1)
-
Conclusions (2)
|
Author: P.
Michielsen, R. Brenard, H. Reynaert
|